TARA

NASDAQ · Biotechnology

Protara Therapeutic Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.48

+0.00 (+0.00%)

As of Nov 7, 2:11 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 13 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target +845.2% upside

Low Target $15.10

Average Target $23.44

High Target $28.04

Current Price $2.48

Current
$2.48

Target
$23.44

$15.10 $23.44 avg $28.04

Scenario Analysis

Bear Case

$15.10

508.9%

Low target

Base Case

$23.44

+845.2%

Avg target

Bull Case

$28.04

+1,030.6%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$7.82

-68.3% from high

52-Week Low

$2.11

+17.5% from low

Target vs 52W High

$23.44

+199.7% vs high

Next Earnings Report

Nov 9, 2026

tomorrow

EPS Est: $-0.37

Earnings in 1 days. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-11.6%
AMGN Amgen Inc	Hold	42	43%	$190.87	-58.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+117.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-19.9%
MRNA Moderna Inc	Hold	31	35%	$149.45	-41.2%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-91.5%
NTRA Natera Inc	Strong Buy	30	90%	$142.91	-54.0%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-40.7%